Inhaled Nitric Oxide Market size to Reach USD 1.65 Billion by 2031, Growth Driven by Generator-Based Systems and Expanding Critical Care Use

Inhaled Nitric Oxide Market Analysis 

According to Mordor Intelligence, the inhaled nitric oxide market size is projected to grow from USD 1.02 billion in 2025 to USD 1.10 billion in 2026, reaching USD 1.65 billion by 2031, registering a CAGR of 8.29% during the forecast period. The inhaled nitric oxide market forecast reflects consistent demand from neonatal intensive care units, growing adult respiratory applications, and increasing hospital preference for cylinder-free systems. 

The inhaled nitric oxide industry plays a vital role in respiratory care, particularly in treating persistent pulmonary hypertension of the newborn and acute respiratory distress syndrome. Hospitals worldwide continue to integrate nitric oxide therapy into ventilation strategies. With sustained reimbursement support in developed markets and expanding intensive care capacity in emerging economies, the inhaled nitric oxide market growth outlook remains stable. 

Inhaled Nitric Oxide Market Trends Shaping Industry Expansion 

Rising Burden of Neonatal and Acute Pulmonary Disorders 

One of the key inhaled nitric oxide market trends is the steady demand from neonatal care. Persistent pulmonary hypertension in newborns remains a primary indication, ensuring continuous usage in NICUs. As more countries strengthen neonatal care guidelines, the inhaled nitric oxide industry benefits from standardized treatment protocols. 

Shift Toward Cylinder-Free Generator Technologies 

Hospitals are increasingly evaluating generator-based nitric oxide systems. These devices eliminate the need for high-pressure gas cylinders and reduce storage and transportation challenges. This shift represents a major inhaled nitric oxide market trend. 

Favorable Reimbursement in High-Income Countries 

Reimbursement frameworks in developed markets continue to support therapy adoption. Coverage under established billing codes in certain countries ensures that hospitals can justify investment in nitric oxide delivery systems. This has stabilized revenue streams and supports long-term inhaled nitric oxide market growth. 

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/inhaled-nitric-oxide?utm_source=industrytoday  

Inhaled Nitric Oxide Market Segmentation Analysis 

By Product Type 

• Inhaled Nitric Oxide Gas 
• Nitric Oxide Generators and Delivery Systems 
• Integrated Ventilator Modules 
• Accessories and Consumables 

By Application 

• Neonatal Respiratory Treatment 
• Asthma and COPD 
• Acute Respiratory Distress Syndrome 
• Malaria Treatment 
• Tuberculosis Treatment 
• Other Applications 

By End-User 

• Tertiary Hospitals and NICUs 
• Specialty Pulmonary Clinics 
• Ambulatory Surgical Centres 
• Home-Care Settings 

By Geography 

• North America 
• Europe 
• Asia-Pacific 
• Middle East and Africa 
• South America 

Explore Our Full Library of Healthcare Research Report: https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=industrytoday  

Inhaled Nitric Oxide Market Competitive Landscape 

The inhaled nitric oxide industry is moderately consolidated, with established gas suppliers and specialized device manufacturers competing across product categories. Market participants focus on delivery systems, distribution partnerships, and regulatory approvals to maintain their inhaled nitric oxide market share. 

Key Players in the Inhaled Nitric Oxide Market 

• Mallinckrodt Pharmaceuticals plc 
• Linde plc 
• Air Liquide Healthcare 
• VERO Biotech LLC 
• Beyond Air Inc. 

Explore more insights on inhaled nitric oxide competitive landscape: https://www.mordorintelligence.com/industry-reports/inhaled-nitric-oxide/companies?utm_source=industrytoday  

Conclusion 

The inhaled nitric oxide market forecast indicates continued expansion supported by neonatal respiratory care, adult critical care applications, and improved healthcare infrastructure in emerging regions. While cost and regulatory compliance remain considerations, technology shifts toward generator-based systems are reshaping procurement strategies. 

With stable reimbursement frameworks in developed countries and growing hospital investments in advanced respiratory platforms, the inhaled nitric oxide market size is positioned for consistent progress. As applications broaden and care settings diversify, the inhaled nitric oxide industry is expected to maintain balanced growth across product categories and geographies. 

Get detailed insights on the inhaled nitric oxide market: https://www.mordorintelligence.com/industry-reports/inhaled-nitric-oxide?utm_source=industrytoday  

Industry Related Reports 

Sterilization Indicator Tape Market:  https://www.mordorintelligence.com/industry-reports/sterilization-indicator-tape-market?utm_source=industrytoday 

Laboratory Supplies Market Size:  https://www.mordorintelligence.com/industry-reports/laboratory-supplies-market?utm_source=industrytoday 

Subcutaneous Drug Delivery Devices Market Share: https://www.mordorintelligence.com/industry-reports/subcutaneous-drug-delivery-devices-market?utm_source=industrytoday 

About Mordor Intelligence: 

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. 

For any inquiries or to access the full report, please contact: 

media@mordorintelligence.com 

https://www.mordorintelligence.com/